Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
abacavir (ziagen) (1 trial)
amprenavir (agenerase) (1 trial)
didanosine (videx) (1 trial)
efavirenz (sustiva) (1 trial)
enfuvirtide (fuzeon) (1 trial)
indinavir (crixivan) (1 trial)
lamivudine (epivir) (1 trial)
nelfinavir (viracept) (1 trial)
nevirapine (viramune) (1 trial)
ritonavir (Norvir) (1 trial)
saquinavir (invirase) (1 trial)
stavudine (zerit) (1 trial)
tenofovir (viread) (1 trial)
tipranavir (aptivus) (1 trial)
zidovudine (retrovir) (1 trial)
Cardiovascular Diseases (Phase 4)
HIV-Associated Lipodystrophy Syndrome (Phase 4)
Lipodystrophy (Phase 4)
Trials (1 total)
Trial APIs (15 total)